TOPIC

Peptides & Peptide Hormones

Peptides & Peptide HormonesHigh — multiple phase 3 trials and approved indications

Semaglutide

Semaglutide is classified here as glp-1 receptor agonist peptide. Evidence level: High — multiple phase 3 trials and approved indications.

→

Peptides & Peptide HormonesClinical development history but limited evidence for current fitness claims

AOD-9604

AOD-9604 is classified here as modified growth-hormone fragment. Evidence level: Clinical development history but limited evidence for current fitness claims.

→

Peptides & Peptide HormonesHigh — phase 3 obesity/diabetes programs and approved indications

Tirzepatide

Tirzepatide is classified here as dual gip/glp-1 receptor agonist peptide. Evidence level: High — phase 3 obesity/diabetes programs and approved indications.

→

Peptides & Peptide HormonesHuman endocrine and fertility research

Kisspeptin

Kisspeptin is classified here as hypothalamic reproductive neuropeptide. Evidence level: Human endocrine and fertility research.

→

Peptides & Peptide HormonesModerate-to-high investigational evidence; phase 2 and phase 3 development

Retatrutide

Retatrutide is an investigational triple receptor agonist with substantial weight-loss effects in phase 2 research and ongoing later-stage development.

→

Peptides & Peptide HormonesHigh for its approved indication; not a performance drug

Bremelanotide (PT-141)

Bremelanotide (PT-141) is classified here as melanocortin receptor agonist peptide. Evidence level: High for its approved indication; not a performance drug.

→